ArticleA model-based cost-effectiveness analysis of pharmacogenomic panel testing in cardiovascular disease management: preemptive, reactive, or none?
Under a Creative Commons license
open access
Key words
pharmacogenomics
cost-effectiveness
genomic panel testing
cardiovascular diseases management
Cited by (0)
© 2021, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics